Providence Capital Advisors »

Fate Therapeutics shares owned by Providence Capital Advisors

Quarter-by-quarter ownership of Fate Therapeutics (FATE) shares owned by Providence Capital Advisors from 13F filings

Historical chart of Providence Capital Advisors investment in Fate Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Fate Therapeutics held by Providence Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Fate Therapeutics by Providence Capital Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $448 61 7.34
2023-09-30 $129 61 2.11
2023-06-30 $290 61 4.75
2023-03-31 $347 61 5.70
2022-12-31 $615 61 10.08
2022-09-30 $999 61 16.39
2022-06-30 $2.0k 61 32.79
2022-03-31 $3.0k 78 38.46
2021-12-31 $4.0k 61 65.57
2021-09-30 $4.0k 61 65.57
2021-06-30 $5.0k 61 81.97
2021-03-31 $5.0k 61 81.97
2020-12-31 $8.0k 91 87.91